ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2018

Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study.

György Jermendy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.